These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32479245)

  • 41. The First Negative Allosteric Modulator for Dopamine D
    Rossi M; Fasciani I; Marampon F; Maggio R; Scarselli M
    Mol Pharmacol; 2017 Jun; 91(6):586-594. PubMed ID: 28265019
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A biphasic opioid function modulator: agmatine.
    Su RB; Li J; Qin BY
    Acta Pharmacol Sin; 2003 Jul; 24(7):631-6. PubMed ID: 12852826
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Trafficking of central opioid receptors and descending pain inhibition.
    Bie B; Pan ZZ
    Mol Pain; 2007 Dec; 3():37. PubMed ID: 18053223
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular insights into allosteric modulation of Class C G protein-coupled receptors.
    Leach K; Gregory KJ
    Pharmacol Res; 2017 Feb; 116():105-118. PubMed ID: 27965032
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular Mechanisms of Biased and Probe-Dependent Signaling at CXC-Motif Chemokine Receptor CXCR3 Induced by Negative Allosteric Modulators.
    Brox R; Milanos L; Saleh N; Baumeister P; Buschauer A; Hofmann D; Heinrich MR; Clark T; Tschammer N
    Mol Pharmacol; 2018 Apr; 93(4):309-322. PubMed ID: 29343553
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Harnessing allostery: a novel approach to drug discovery.
    Lu S; Li S; Zhang J
    Med Res Rev; 2014 Nov; 34(6):1242-85. PubMed ID: 24827416
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Redoubling the ring size of an endomorphin-2 analog transforms a centrally acting mu-opioid receptor agonist into a pure peripheral analgesic.
    Piekielna J; De Marco R; Gentilucci L; Cerlesi MC; Calo' G; Tömböly C; Artali R; Janecka A
    Biopolymers; 2016 May; 106(3):309-17. PubMed ID: 27038094
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Delineation of the functional properties and the mechanism of action of AA29504, an allosteric agonist and positive allosteric modulator of GABA
    Olander ER; Madjroh N; Bunch L; Söderhielm PC; Jensen AA
    Biochem Pharmacol; 2018 Apr; 150():305-319. PubMed ID: 29454619
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evidence from basic research for opioid combinations.
    Davis MP
    Expert Opin Drug Discov; 2012 Feb; 7(2):165-78. PubMed ID: 22468917
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Allosteric modulation of G protein-coupled receptors.
    May LT; Avlani VA; Sexton PM; Christopoulos A
    Curr Pharm Des; 2004; 10(17):2003-13. PubMed ID: 15279541
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis of iboga-like isoquinuclidines: Dual opioid receptors agonists having antinociceptive properties.
    Banerjee TS; Paul S; Sinha S; Das S
    Bioorg Med Chem; 2014 Nov; 22(21):6062-70. PubMed ID: 25281271
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Novel Allosteric Modulators of G Protein-coupled Receptors.
    Gentry PR; Sexton PM; Christopoulos A
    J Biol Chem; 2015 Aug; 290(32):19478-88. PubMed ID: 26100627
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Homobivalent Conjugation Increases the Allosteric Effect of 9-aminoacridine at the α1-Adrenergic Receptors.
    Campbell AP; Wakelin LP; Denny WA; Finch AM
    Mol Pharmacol; 2017 Feb; 91(2):135-144. PubMed ID: 27903755
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development of opioid peptide analogs for pain relief.
    Janecka A; Perlikowska R; Gach K; Wyrebska A; Fichna J
    Curr Pharm Des; 2010; 16(9):1126-35. PubMed ID: 20030621
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Attacking pain at its source: new perspectives on opioids.
    Stein C; Schäfer M; Machelska H
    Nat Med; 2003 Aug; 9(8):1003-8. PubMed ID: 12894165
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ultra-low dose naloxone restores the antinociceptive effect of morphine in pertussis toxin-treated rats by reversing the coupling of mu-opioid receptors from Gs-protein to coupling to Gi-protein.
    Tsai RY; Tai YH; Tzeng JI; Cherng CH; Yeh CC; Wong CS
    Neuroscience; 2009 Dec; 164(2):435-43. PubMed ID: 19682558
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Involvement of Opioid Receptors and α
    Vo L; Hood S; Drummond PD
    J Pain; 2016 Nov; 17(11):1164-1173. PubMed ID: 27497768
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Discovery of dual-acting opioid ligand and TRPV1 antagonists as novel therapeutic agents for pain.
    Lee H; Ahn S; Ann J; Ha H; Yoo YD; Kim YH; Hwang JY; Hur KH; Jang CG; Pearce LV; Esch TE; Lewin NE; Blumberg PM; Lee J
    Eur J Med Chem; 2019 Nov; 182():111634. PubMed ID: 31472474
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Opioid receptors on peripheral sensory neurons.
    Stein C
    Adv Exp Med Biol; 2003; 521():69-76. PubMed ID: 12617565
    [No Abstract]   [Full Text] [Related]  

  • 60. Interplay between Two Allosteric Sites and Their Influence on Agonist Binding in Human μ Opioid Receptor.
    Bartuzi D; Kaczor AA; Matosiuk D
    J Chem Inf Model; 2016 Mar; 56(3):563-70. PubMed ID: 26863088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.